跳至主要内容
临床试验/JPRN-UMIN000029020
JPRN-UMIN000029020已完成未知

Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome 2017 - Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome 2017

Ehime University Hospital0 个研究点目标入组 10 人开始时间: 2017年9月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who are revealed of SFTSV load decreasing or had improvements of clinical manifestation 2. Patients who had been running fever while seven or more days 3. Patients who are treated for severe hepatic disease (Child-Pugh grade C) 4. Pregnant women or patients who might be pregnant 5. Patients who have difficulty in taking the extremely effective contraception during the first day of treatment with favipiravir until 7days after the medication 6. Patients who suffer from hereditary xanthinuria 7. Patients who have hypouriceia (less than 1mg/dl) or had been made a diagnosis of urinary tract xanthine calculus 8. Patients who have a history of hyper sensitivity for favipiravir 9. Patients who are inadequate for enrollment for this protocol with the investigator's judgment

研究者

相似试验

Clinical study of favipiravir for patients with... | 临床试验